Log in

Start Your Membership Now

On October 14, 2021, the U.S. Centers for Disease Control and Prevention (CDC) added bipolar disorder and schizophrenia to the list of high-risk underlying medical conditions that are associated with higher risk of severe illness due to coronavirus disease 2019 (COVID-19). These conditions were added to the list based on the strength of evidence revealed by at least one meta-analysis or systematic review, or by review method defined in a scientific evidence brief.

The CDC’s decision to add bipolar disorder and schizophrenia was based on the findings in two studies structured as systematic reviews and . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Tagged As: